Discontinued — last reported Q4 '20
Current Assets
Available-for-Sale Debt Securities - Amortized Cost
Amgen Available-for-Sale Debt Securities - Amortized Cost increased by 16.3% to $8.71B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $8.58B to $8.71B. Over 4 years (FY 2020 to FY 2024), Available-for-Sale Debt Securities - Amortized Cost shows an upward trend with a 3.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2020
How to read this metric
An increase reflects new debt security purchases, while a decrease indicates maturities or sales of existing holdings.
Detailed definition
This represents the original cost of debt securities classified as available-for-sale, adjusted for amortization of prem...
Peer comparison
Standard accounting metric; allows for comparison of investment cost bases across financial institutions.
Metric ID:
afs_debt_securities_amortized_costHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.16B | $12.28B | $7.30B | $5.85B | $6.41B | $10.92B | $4.34B | $31.07B | $33.62B | $34.21B | $10.40B | $9.24B | $8.81B | $8.58B | $11.49B | $8.30B | $7.49B | $8.71B |
| QoQ Change | — | +71.5% | -40.5% | -19.9% | +9.6% | +70.3% | -60.3% | +616.6% | +8.2% | +1.8% | -69.6% | -11.2% | -4.6% | -2.7% | +33.9% | -27.7% | -9.8% | +16.3% |
| YoY Change | — | — | — | — | -10.4% | -11.0% | -40.6% | +430.8% | +424.2% | +213.2% | +140.0% | -70.3% | -73.8% | -74.9% | +10.4% | -10.1% | -15.0% | +1.5% |
Range$4.34B – $34.21B
CAGR+4.7%
Avg YoY Growth+65.3%
Median YoY Growth-10.3%
Available-for-Sale Debt Securities - Amortized Cost at Other Companies
Frequently Asked Questions
- What is Amgen's available-for-sale debt securities - amortized cost?
- Amgen (AMGN) reported available-for-sale debt securities - amortized cost of $8.71B in Q3 2025.
- How has Amgen's available-for-sale debt securities - amortized cost changed year-over-year?
- Amgen's available-for-sale debt securities - amortized cost increased by 1.5% year-over-year, from $8.58B to $8.71B.
- What is the long-term trend for Amgen's available-for-sale debt securities - amortized cost?
- Over 4 years (2020 to 2024), Amgen's available-for-sale debt securities - amortized cost has grown at a 3.9% compound annual growth rate (CAGR), from $9.84B to $11.49B.
- What does available-for-sale debt securities - amortized cost mean?
- The original purchase price of debt investments, adjusted for accounting adjustments, excluding current market price changes.